Translational Drug Development
As a contract research organization (CRO) specializing in oncology and precision medicine, Translational Drug Development (TD2) collaborates with innovative biotech and pharmaceutical companies to expedite the delivery of treatments for rare cancers to patients. TD2 offers exclusive access to its Oncology Ecosystem, which includes services for clinical trial management, regulatory support, and preclinical studies. This comprehensive support aims to maximize the success of your research.
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters